Related Experiment Video
Updated: Oct 1, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
The interface of COVID-19, diabetes, and depression
Charlotte Steenblock1, Peter E H Schwarz1,2,3, Nikolaos Perakakis1,2,3
1Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
Insights
Comorbid depression and diabetes are linked, with both conditions increasing risks during the COVID-19 pandemic. Increased awareness and trained professionals are crucial for managing these interconnected health challenges.
Area of Science:
- Medical research
- Public health
- Epidemiology
Background:
- Comorbid diabetes and depression present a significant clinical challenge, often overlooked.
- The COVID-19 pandemic exacerbates non-communicable diseases like diabetes and depression, creating a complex interplay.
- These conditions exhibit bidirectional relationships, where depression increases diabetes risk and vice versa.
Purpose of the Study:
- To highlight the critical interface between depression, diabetes, and COVID-19.
- To underscore the need for increased awareness regarding the comorbidity of these conditions.
- To emphasize the necessity of training healthcare professionals in managing these overlapping conditions.
Main Methods:
- Literature review and synthesis of existing research on the comorbidity of depression, diabetes, and COVID-19.
- Analysis of the bidirectional relationships and cyclical nature of these health issues.
- Examination of the impact of pandemic-related measures on mental health and chronic disease management.
Main Results:
- Depression is a risk factor for developing diabetes, and diabetes increases the likelihood of depressive symptoms.
- Diabetic patients face a higher risk of severe COVID-19 and breakthrough infections.
- Both type 2 diabetes patients and COVID-19 survivors show an increased prevalence of depression.
- Pandemic lockdowns and quarantines have contributed to a rise in depression rates.
Conclusions:
- The interconnectedness of depression, diabetes, and COVID-19 necessitates greater clinical and public health attention.
- Overlapping symptoms among post-COVID conditions, diabetes, and depression require specialized management strategies.
- Educating healthcare personnel is vital for effectively addressing the complex comorbidity of these widespread health issues.
Abstract:
Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connected forming a vicious cycle. Firstly, depressed individuals show a higher risk of developing diabetes and patients with diabetes have a higher risk of developing symptoms of depression. Secondly, patients with diabetes have a higher risk of developing severe COVID-19 as well as of experiencing breakthrough infections. Thirdly, in both patients with type 2 diabetes and in COVID-19 survivors the prevalence of depression seems to be increased. Fourthly, lockdown and quarantine measurements during the COVID-19 pandemic has led to an increase in depression. Therefore, it is of importance to increase the awareness of this interface between depression, diabetes and COVID-19. Finally, as symptoms of post-COVID, diabetes and depression may be overlapping, there is a need for educating skilled personnel in the management of these comorbidities.
More Related Videos
Related Concept Videos
Depression: Overview
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

